More Alzheimer's drug trial failures: are researchers on the wrong track?

(HealthDay)—Amyloid beta has long been a prime suspect in Alzheimer's disease, since abnormal levels of the protein form disruptive plaques between patients' brain cells.

* This article was originally published here